MNTA
Momenta Pharmaceuticals Inc.

1,010
Loading...
Loading...
Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
118

Frequently Asked Questions

What is Market Cap of Momenta Pharmaceuticals Inc?
What is the 52-week high for Momenta Pharmaceuticals Inc?
What is the 52-week low for Momenta Pharmaceuticals Inc?
What is Momenta Pharmaceuticals Inc stock price today?
What was Momenta Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Momenta Pharmaceuticals Inc?
What is the Price-to-Book ratio of Momenta Pharmaceuticals Inc?
What is Momenta Pharmaceuticals Inc's EBITDA?
What is the 50-day moving average of Momenta Pharmaceuticals Inc?
How many employess does Momenta Pharmaceuticals Inc has?

Latest MNTA News

View
No MNTA news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.